Connie Montgomery: Every Patient Deserves Representation in Clinical Research
Connie Montgomery, National Member Board of Trustees Camden Coalition at Camden Coalition, shared American Society of Hematology‘s a post on LinkedIn:
“Trialport supports that all people need to be represented in clinical trials especially for those of us living with bleeding disorders and other diseases.”
American Society of Hematology shared a post on LinkedIn:
“Representation in clinical trials doesn’t improve by accident—it improves by design.
The ASH Toolkit for Clinical Trial Sponsors provides a step-by-step, practical resource to build equity into the trial life cycle from the outset.
Find concrete recommendations, examples, and curated references to help enhance access, broaden participation, and generate results that truly reflect the patients impacted by the disease or therapy.
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal